Sign in Create account

Smruthi Organics Limited

Healthcare · Pharmaceuticals & Biotechnology

BSE: 540686
₹158.50
▲ 2.55 (1.64%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
64/100
Moderate
Valuation
71/100
Undervalued
Momentum
35/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹181 Cr
PE (TTM)
24.3
Industry median 36.1 (152 companies)
Price to Book
2.5
PEG (TTM)
0.2
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
33.4
Free Cash Flow
₹14 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
367.71%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
89.48%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-4.63%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-52.15%
as of March 31, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
54.29%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.98
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.11
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
7.62
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
3.67%
as of March 31, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
14.47%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
10.40%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
6.52%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
8.25%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
9.18%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.11)
  • No Return on equity is 15% or more (9.2%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

3 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.6%
Low 157.0000 · High 173.7000
1W return
-2.1%
Low 148.4000 · High 173.7000
1M return
11.5%
Low 135.3000 · High 175.3000
52W return
33.4%
Low 114.4000 · High 175.3000
Lifetime High ₹793.0000 (March 15, 2021)
Lifetime Low ₹65.1000 (March 24, 2020)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish5
Bearish1
5D
157.5
10D
157.5
20D
155.0
50D
152.2
100D
155.5
200D
164.0

Delivery and volume

Day avg. delivery
82.9%
Week avg. delivery
74.1%
Month avg. delivery
77.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

163.07
Pivot
First resistance169.13
Second resistance179.77
Third resistance185.83
First support152.43
Second support146.37
Third support135.73
Day RSI54.5
Day MFI30.8
Day MACD3.42
Day MACD signal3.99

Beta

1M0.85
3M0.44
1Y0.44
3Y0.69

Price change analysis

↑ 11.5%
Over 1 Month
LowHigh
135.30175.30
↑ 33.4%
Over 3 Months
LowHigh
114.40175.30
↑ 33.4%
Over 6 Months
LowHigh
114.40175.30
↑ 33.4%
Over 1 Year
LowHigh
114.40175.30
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 24.3 (own history: 18.2–495.6)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹29 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹2.5700

Ranks #121 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter64.73%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 64.73% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 11 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
22 Jul 2021 ALPHA LEON ENTERPRISES LLP Bulk Buy 30,695 325.4100 BSE
22 Jul 2021 ALPHA LEON ENTERPRISES LLP Bulk Sell 39,177 326.0200 BSE
19 Jul 2021 ALPHA LEON ENTERPRISES LLP Bulk Sell 2,596 360.8800 BSE
19 Jul 2021 ALPHA LEON ENTERPRISES LLP Bulk Buy 39,695 360.5000 BSE
12 Apr 2021 MANISHKUMARGOYAL Bulk Buy 21,465 255.3700 BSE
6 Jan 2021 RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED Bulk Sell 41,826 580.1400 BSE
5 Jan 2018 RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED Bulk Buy 25,000 101.8500 BSE
5 Jan 2018 DILIP KUMAR RUNGTA Bulk Sell 28,868 101.8500 BSE
8 Dec 2017 JAIRAM RAMCHAND JHAMTANI Bulk Sell 20,000 87.6800 BSE
7 Dec 2017 DHEERAJ KUMAR LOHIA Bulk Buy 22,819 84.3400 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Insider Trading / SAST Smruthi Organics Ltd - 540686 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.11)
  • Healthy liquidity (Current Ratio 1.98)
  • Strong revenue growth YoY (54.3%)

Weaknesses

  • Low Return on Equity (9.2%)
  • Thin net profit margin (3.7%)
  • Declining profit YoY (-52.2%)

Opportunities

  • PEG below 1 (0.20) -- earnings growth outpacing its own valuation

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Smruthi Organics Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.